Our CEO Liz Parrish spoke at Wired Health 2017 about why: Aging is a disease. Gene therapy could be the ‘cure’

“She (Liz Parrish) had spent more than two years studying literature, talking to experts, and had decided to undergo gene therapy – a treatment for genetic disorders that adds genes into cells to replace those that are faulty or absent.”

“I was a person who quite honestly felt I had not really contributed that much to society and this was my opportunity to do so.”

“The company was built essentially to prove these therapies work or not,” Parrish says. “Remember BioViva is not a research organisation. We are taking things like gene therapies and using them like technology. We would like to create an open market where people have access to acquiring these technologies, much like you would acquire a cellphone or a computer.”